Elsevier Inc.

SHERPA: Unknown

People

  1. Jakubowski
    Jakubowski
  2. Papadopoulos
    Papadopoulos
  3. Castro-Malaspina
    Castro-Malaspina
  4. Perales
    Perales
  5. Giralt
    Giralt
  6. Young
    Young
  7. O'Reilly
    O'Reilly
  8. Van Den Brink
    Van Den Brink
  9. Ponce
    Ponce
  10. Devlin
    Devlin

Groups

  1. Bone Marrow Transplant (36)
  2. Center for Hematologic Malignancies (36)
  3. Department of Medicine (36)
  4. Hematologic Malignancies, Division of (36)
  5. Survivorship Research (36)
  6. GSK Faculty (30)
  7. Immunology Program Faculty (30)
  8. Sloan Kettering Institute Faculty (30)
  9. Pediatrics, Department of (28)
  10. Stem Cell Transplantation and Cellular Therapy Service (28)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Guenther Koehne"
  3. "Ann Jakubowski"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (14)
Groups
  1. Bone Marrow Transplant (36)
  2. Center for Hematologic Malignancies (36)
  3. Department of Medicine (36)
  4. Hematologic Malignancies, Division of (36)
  5. Survivorship Research (36)
  6. GSK Faculty (30)

More Groups

People
  1. Ann Jakubowski (36)
  2. Guenther Koehne (36)
  3. Esperanza Papadopoulos (35)
  4. Hugo Castro-Malaspina (34)
  5. Miguel-Angel Perales (33)
  6. Sergio Giralt (30)

More People

Years
  1. 2020 (3)
  2. 2018 (2)
  3. 2017 (7)
  4. 2016 (5)
  5. 2015 (3)
  6. 2014 (4)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (36)

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Ex vivo T cell-depleted hematopoietic stem cell transplantation for adult patients with acute myelogenous leukemia in first and second remission: Long-term disease-free survival with a significantly reduced risk of graft-versus-host disease
    Journal Article

    Montoro, J.; Ceberio, I.; Hilden, P.; Maloy, M. A.; Barker, J.; Castro-Malaspina, H.; Dahi, P.; Koehne, G.; Perales, M. A.; Ponce, D.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Impact of toxicity on survival for older adult patients after CD34(+) selected allogeneic hematopoietic stem cell transplantation
    Journal Article

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Borrill, T.; Carlow, D. C.; Avecilla, S. T.; Meagher, R. C.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Graft-versus host disease (GVHD status and severity mediate late effects of allogeneic hematopoietic stem cell transplantation (HSCT) in a 1-year landmark analysis
    Meeting Abstract

    Sola, M.; Devlin, S. M.; Maloy, M.; Dierov, D.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Combining the disease risk index (DRI) and hematopoietic cell transplantation comorbidity index (HCT-CI) provides a comprehensive prognostic model for CD34-selected allogeneic HCT
    Meeting Abstract

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Maloy, M.; Meagher, R.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A chemotherapy-only regimen of busulfan, melphalan, and fludarabine, and rabbit antithymocyte globulin followed by allogeneic T-cell depleted hematopoietic stem cell transplantations for the treatment of myeloid malignancies
    Journal Article

    Spitzer, B.; Jakubowski, A. A.; Papadopoulos, E. B.; Fuller, K.; Hilden, P. D.; Young, J. W.; Barker, J. N.; Koehne, G.; Perales, M. A.; Hsu, K. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies
    Journal Article

    Kosuri, S.; Herrera, D. A.; Scordo, M.; Shah, G. L.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Carlow, D. C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • T cell depletion as an alternative approach for patients 55 years or older undergoing allogeneic stem cell transplantation as curative therapy for hematologic malignancies
    Journal Article

    Jakubowski, A. A.; Petrlik, E.; Maloy, M.; Hilden, P.; Papadopoulos, E.; Young, J. W.; Boulad, F.; Castro-Malaspina, H.; Tamari, R.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save